Semi‐automated thresholding technique for measuring lesion volumes in multiple sclerosis: effects of the change of the threshold on the computed lesion loads

Quantitative evaluation of lesion load in multiple sclerosis (MS) from magnetic resonance imaging (MRI) scans is becoming important in understanding and monitoring the progression of the disease. Methods of MS lesion segmentation based on intensity thresholding offer one of the most robust and easily‐implemented means of computing the total lesion volume. This study evaluated the effects of slight changes in the choice of intensity threshold on computed lesion volumes in 20 patients with MS using such a technique. After judging the optimum choice of threshold value, the threshold value was increased and decreased by 3% in 1% steps around this value; we observed a mean change of 15% in computed lesion volumes for 1% changes of threshold value. Larger changes in lesion volume were found when the threshold was changed by larger amounts. On the other hand, the amount of time required for manual review decreased, and the confidence with which manual review could be performed increased when using lower thresholds. This study shows that the choice of threshold is a crucial factor in measuring lesion volumes in MS when using intensity‐based techniques. It also suggests that in multicenter and/or longitudinal studies, criteria for choosing the threshold should be developed whereby the threshold level should be set such that all MR visible lesions are above it, in order to minimise the human interaction and, consequently, the reproducibility of the results.

[1]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[2]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[3]  J. Olesen,et al.  In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis , 1988, Magnetic resonance in medicine.

[4]  D. Li,et al.  Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features , 1989, Annals of neurology.

[5]  V. Haughton,et al.  Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis , 1989, Neurology.

[6]  A J Petkau,et al.  Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluation , 1990, Neurology.

[7]  R. Kikinis,et al.  Three-dimensional segmentation of MR images of the head using probability and connectivity. , 1990, Journal of computer assisted tomography.

[8]  A. Alavi,et al.  Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. , 1991, Radiology.

[9]  D. Paty,et al.  Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation , 1991, Neurology.

[10]  A. Alavi,et al.  Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part I. Methods, reliability, and validation. , 1991, Radiology.

[11]  J. Friedman,et al.  Quantitative MRI studies for assessment of multiple sclerosis , 1992, Magnetic resonance in medicine.

[12]  R. Knobler,et al.  Neuropsychological and structural brain lesions in multiple sclerosis , 1992, Neurology.

[13]  The Use of Magnetic Resonance Imaging in Monitoring Interferon Therapy of Multiple Sclerosis , 1993, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[14]  D. Paty,et al.  Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.

[15]  W. I. McDonald,et al.  Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis , 1994, Neurology.

[16]  D. Li,et al.  Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis , 1994, Annals of neurology.

[17]  P. Matthews,et al.  Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis , 1994, Annals of neurology.

[18]  A. Fenster,et al.  Computer‐assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain , 1994, Journal of magnetic resonance imaging : JMRI.

[19]  D. Miller,et al.  Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon‐β , 1994, Annals of neurology.

[20]  D. Miller,et al.  Magnetic resonance in monitoring the treatment of multiple sclerosis , 1994, Annals of neurology.